MGAT4B and early-onset autosomal dominant Alzheimer disease: Because the expression levels of each N-glycan branch on specific glycoproteins are highly correlated with various diseases, such as cancer, diabetes, and Alzheimer’s disease [35], GnT-IVb may be a potential drug target to combat these diseases.